The neuronal migration protein doublecortin (DCX) that associates with microtubules through a tandem DCX repeat, is required for the development of the complex architecture of the human cerebral cortex. Using a yeast two-hybrid screen with Dcx as bait, we have isolated neurabin II/spinophilin, an F-actin binding protein known to play a role in dendritic spine formation. The coiled-coil domain of neurabin II binds to a DCX region encompassing the C-terminal portion of the second DCX repeat and the N-terminal portion of the Ser/Pro-rich domain. Immunoprecipitation experiments with brain extracts show that neurabin II and Dcx interact in vivo. Several Dcx constructs that mimic human DCX mutant alleles failed to interact with neurabin II. Since Dcx and neurabin II colocalized in the developing and adult brain, a neurabin II-DCX heterodimer may be involved in neuronal migration and dendritic spine formation. q
Introduction
Doublecortin (DCX) is one of a number of proteins that mediate neuronal migration in the developing cerebral cortex (reviewed in Gleeson and Walsh, 2000; Feng and Walsh, 2001; Gupta et al., 2002) . Mutations in the human X-linked DCX gene result in lissencephaly in males and subcortical laminar heterotopia (SCLH) in females (Pinard et al., 1994; des Portes et al., 1998; Gleeson et al., 1998) . Lissencephaly is characterized by a disorganized cerebral cortex caused by aberrant neuronal migration and poor formation of gyri and sulci. Clinical features associated with lissencephaly are mental retardation and epilepsy (Aicardi, 1991) . SCLH, a mild form of lissencephaly, is characterized by a heterotopic band of neurons located in the white matter underlying the cortex. Since X-chromosomal genes are randomly inactivated, only in a fraction of migrating neuroblasts will both DCX alleles be mutant. It is believed that the population of homozygous mutant cells form the subcortical band of neurons.
DCX encodes a 40 kDa cytoplasmic protein consisting of 360 amino acids. N-terminally, DCX contains two repeats that bind to microtubules. DCX is thus a microtubuleassociated protein (MAP) that binds to tubulin and microtubules. Furthermore, DCX can induce microtubule polymerization and also stabilizes microtubules Gleeson et al., 1999; Horesh et al., 1999) . The C-terminal portion of DCX is rich in Ser and Pro and contains a tetrapeptide (YLPL) that interacts with the clathrin-associated protein m1A (Friocourt et al., 2001 ; our unpublished results). m1A is a subunit of the heterotetrameric AP-1 adaptor complex required in the clathrinmediated vesicular transport between trans-Golgi network, (TGN) and endosomal compartments (Kirchhausen, 1999; Pearse et al., 2000) .
In the mouse, Dcx is strongly expressed in migrating and differentiating neurons suggesting a role of this protein in these processes. Despite the severe consequences of DCX mutations in humans, when Dcx is knocked-out in mice, neocortical neurogenesis and lamination as well as neuronal migration are largely indistinguishable from wild-type (Corbo et al., 2002) . Dcx 2/2 mice, however, show abnormal hippocampal architecture and have a defective hippocampus-based learning (Corbo et al., 2002) . Furthermore, heterozygous knock-out mice for another lissencephaly related gene, Lis1 (Pafah1b1), have shown dendritic defects (fewer branches, reduced total dendritic length, etc.) in heterotopic pyramidal neurons in hippocampus (Fleck et al., 2000) . Lis1 has also been shown to be involved in neuroblast proliferation, dendritic elaboration and axonal transport in Drosophila (Liu et al., 2000) . Taken together, these results raise the possibility that DCX protein, in addition to its role in neuronal migration, has other functions, as is the case with Lis1.
A powerful strategy to explore the mechanism of action of a protein is to search for its interacting proteins. Here, we have undertaken a yeast two-hybrid screen with Dcx and have isolated neurabin II/spinophilin, an F-actin binding protein (Allen et al., 1997; Satoh et al., 1998) . We demonstrate Dcx -neurabin II interaction through multiple methods, show that introduction of certain human DCX mutations in Dcx cause the loss of interaction with neurabin II, and show that both neurabin II and Dcx are coexpressed in many regions of the developing brain and in primary cultures of hippocampal neurons.
Results

Mouse neurabin II was isolated as a Dcx-interacting protein
In order to identify Dcx-interacting proteins, a GAL4-based yeast two-hybrid screen was performed using the entire mouse Dcx open reading frame as bait and a yeast two-hybrid library derived from E17 whole mouse embryos (Sweeny et al., 2000) . Of approximately 10 6 transformants, 57 clones were isolated that grew on plates lacking tryptophan (Trp), leucine (Leu), and adenine (Ade). Fifty of these clones also grew on the selective plates (either lacking Trp, Leu, and histidine or Trp, Leu and Ade) when co-transformed with empty pAS2-1 vector. Seven clones, however, grew only on selective plates when co-transformed with pAS2-1-Dcx (data not shown). Three clones corresponded to m1A protein that had recently been identified as DCX-interacting protein (Friocourt et al., 2001 ). Here we describe another Dcx-interacting protein that was represented by two clones. Clone 262 and 402 (Fig. 1A) showed . 90% nucleotide identity with rat neurabin II/spinophilin. Neurabin II is an F-actin binding protein most abundantly expressed in postnatal brain (Allen et al., 1997) . Neurabin II contains an N-terminal F-actin binding domain, a PDZ (PSD95/discs large/ZO-1) proteinbinding domain and a C-terminal domain predicted to form a coiled-coil structure (Fig. 1A) .
We next isolated full-length mouse neurabin II that was 97.4% identical to rat neurabin II. As shown in Fig. 1B , fulllength neurabin II interacted with Dcx (Fig. 1B, line c) . In addition, the yeast two-hybrid assay showed that neurabin I which has a domain organization and sequence similar to that of neurabin II and is expressed in brain (Nakanishi et al., 1997) , did not interact with Dcx (Fig. 1B, line h ). Neurabin II lacking the C-terminal coiled-coil region (Fig. 1A ) did not interact with Dcx (Fig. 1B, line d) . By contrast, neurabin II clone 262 lacking most of the F-actin binding domain or clone 402 lacking the PDZ and F-actin binding domains showed interaction (Fig. 1C, lines b, g ). Taken together, these data indicate that the coiled-coil region of neurabin II is chiefly responsible for the interaction with Dcx.
In addition to DCX, mammalian genomes contain a related gene termed DCAMKL1 (doublecortin and calcium/calmodulin-dependent protein kinase-like 1). The N-terminal portion of DCAMKL1 is highly homologous to DCX whereas its C-terminal portion encodes a putative Ca 2þ /calmodulin-dependent protein kinase (see Fig. 1D ; Omori et al., 1998; Burgess et al., 1999) . DCAMKL1 is expressed in developing and the adult brain in a pattern similar to DCX (Omori et al., 1998; Mizuguchi et al., 1999) . We found that clone 262 of neurabin II interacted with Dcamkl1 (Fig. 1C, line c) . The identical result was obtained with clone 402 (data not shown). Yeast two-hybrid assays also demonstrated that the kinase domain of Dcamkl1 alone was insufficient to bind to clone 402 (Fig. 1C, line h ). This indicates that the interaction between neurabin II and Dcamkl1 occurs through the doublecortin homology region.
Dcx and neurabin II proteins interact directly
To demonstrate that the interaction between neurabin II and Dcx can also occur in vitro and in mammalian cells, GST pull-down assays and immunoprecipitation experiments were performed. Dcx was translated in the presence of [
35 S]methionine using a transcription/translation protocol. Labelled Dcx was incubated with bacterially expressed GST-neurabin II coiled-coil region (clone 402, Fig. 1A ), GST bound to glutathione sepharose beads or to beads alone. An interaction between Dcx and GST-neurabin II coiled-coil region was observed ( Fig. 2A, lane 5) . By contrast, glutathione sepharose beads or GST alone did not bind to Dcx (Fig. 2A, lanes 1 and 3) . When affinity-purified GST-neurabin II coiled-coil region was incubated with [ 35 S]methionine-labelled Dcamkl1, radiolabelled Dcamkl1 also could be precipitated with GST-neurabin II coiled-coil region bound to glutathione sepharose beads (Fig. 2B , lane 5). These results are consistent with the yeast twohybrid data showing that the C-terminal coiled-coil region of neurabin II binds to Dcx and Dcamkl1.
Next, the protein coding region of Dcx and neurabin II were cloned into pEGFP or pCMV-Tag 2. Fusion proteins EGFP-Dcx and FLAG-neurabin II (Fig. 2C, lane 2) or EGFP and FLAG-neurabin II (Fig. 2C , lane 1) were expressed in COS-7 cells. Western blots of whole cell lysates (WCL) probed with anti-GFP or anti-FLAG antibodies showed that all three proteins were expressed (Fig. 2C , lower two panels, WCL). When an anti-FLAG antibody was used to immunoprecipitate FLAG-neurabin II and the resulting material was analyzed by Western blotting, an anti-GFP antibody detected the EGFP-Dcx fusion protein with a molecular weight of 67 kDa ( transfected with FLAG-neurabin II and EGFP, did not yield a band at the position of EGFP (Fig. 2C , top panel lane 1) demonstrating that neurabin II does not bind to EGFP. When immunoprecipitation was done with an anti-GFP antibody, specific interaction between FLAG-neurabin II and EGFPDcx was also found (Fig. 2C , second panel from top).
Taken together, the yeast two-hybrid assays, GST pulldown assays and immunoprecipitation experiments establish that Dcx directly interacts with neurabin II.
Dcx and neurabin II show coexpression in the telencephalon
DCX is strongly expressed in specific regions of the developing and adult forebrain (Gleeson et al., 1999; Nacher et al., 2001) . If Dcx and neurabin II are destined to interact in the brain, they are expected to show partially overlapping patterns of expression. Therefore, we have examined the expression pattern of neurabin II with a focus on the telencephalon. Consistent with Western blotting data (Allen et al., 1997) , neurabin II expression was low during development but was strongly increased after birth and persisted in the adult brain. At E14.5, in situ hybridization detected neurabin II expression at the outer margin of the cortical plate, in the developing hippocampus and at a lower level in the ventricular zone (Fig. 3A, B) . At E18.5, neurabin II was expressed throughout cortex and hippocampus as well as in the mitral layer of the olfactory bulb (data not shown). In postnatal P7 brain, we observed widespread and strong expression of neurabin II (Fig. 3C,  D) . Expression was most prominent in layers 2 and 3 of the neocortex, in the piriform cortex (Fig. 3C, D) , and the olfactory tubercles (Fig. 3C) . In adult brain, neurabin II transcripts were present in many areas of the brain, but strongest expression was observed in layers 2 and 3 of the neocortex, in the subventricular zone, throughout the cornu amonis and dentate gyrus of the hippocampus, in the septum and in the amygdala (data not shown). ]methionine-labelled Dcx and Dcamkl1 was specifically precipitated (P) only with GST-neurabin II bound to glutathione sepharose beads (lane 5). (C) EGFP (27 kDa), EGFP-Dcx (67 kDa) and FLAG-neurabin II (130 kDa) are present in whole cell lysates (WCL, two lower panels). In the top panel, a FLAG antibody was used to precipitate FLAGneurabin II protein to which EGFP-Dcx was bound and was detected with a GFP antibody (lane 2). The same experiment with EGFP was done as control (lane 1). Accordingly, a Western blot probed with an anti-GFP antibody showed no specific band, indicating the EGFP and FLAG-neurabin II do not interact. In the second panel from the top, a GFP antibody precipitates EGFP-Dcx and simultaneously pulls down FLAG-neurabin II (lane 2). The same experiment with EGFP did not show any interaction of EGFP with FLAG-neurabin II (lane 1).
Many neurabin II-positive structures also expressed Dcx. For example at E15, Dcx mRNA is detected in the cortical plate (Gleeson et al., 1999) and at P7, this gene was also expressed in the neocortex, the piriform cortex and the hippocampus (Fig. 3C, D) . A marked difference between the expression pattern of neurabin II and Dcx was observed in the dentate gyrus (Fig. 3D) . Whereas Dcx mRNA was found throughout the granular layers of cornu amonis and dentate gyrus, neurabin II transcripts were absent in those granular cells of the dentate gyrus facing the polymorphic cell layer (Fig. 3D, insert) . A second difference in expression between neurabin II and Dcx was the absence of neurabin II transcripts in the rostral migratory stream (Fig. 3C, D) that is composed of neurons migrating into the olfactory bulb. Although there are exceptions to the rule, there is a significant overlap of the sites of expression of neurabin II and Dcx in the telencephalon. Thus, these two gene products have the opportunity to interact in vivo during development and in the adult forebrain.
Dcx and neurabin II colocalize in mouse hippocampal neurons and coprecipitate from brain extract
To determine the subcellular distribution of endogenous Dcx and neurabin II proteins, we performed immunofluorescence double labelling studies of mouse primary hippocampal neurons dissected from embryonic day 18.5 mouse brain. Dcx protein was abundant in the periphery of the soma of neurons forming a ring-like distribution around the nucleus (Fig. 4A) . In addition, Dcx-derived fluorescence was strong in most neurites. Of note, such an expression pattern of Dcx had previously been reported (Gleeson et al., 1999; Friocourt et al., 2001) . The staining pattern of neurabin II was similar to that of Dcx (Fig. 4A) . A monoclonal neurabin II antibody stained the cell body except for the nucleus and also neurites. Such an expression pattern of neurabin II in neurites is consistent with its dendritic distribution described previously .
Additional evidence for an in vivo interaction of Dcx and neurabin II was obtained by co-immunoprecipitation from E17.5 brain extracts. As shown in Fig. 4B , immunecomplexes precipitated with a Dcx antibody contained neurabin II. In a control experiment using anti-FLAG antibody, neither Dcx nor neurabin II were precipitated, indicating that the Dcx and neurabin II did not interact with antibody in a non-specific fashion.
Taken together, mRNA and protein colocalization and co-immunoprecipitation of Dcx and neurabin II from brain tissues support the view that Dcx-neurabin II interaction occurs in vivo.
Mutations in Dcx can affect the interaction between neurabin II and Dcx
Point mutations in the human DCX gene causing lissencephaly or SCLH are predominantly located in the doublecortin repeats ( Fig. 1D ; Sapir et al., 2000; Taylor et al., 2000) . In vitro binding experiments have shown that each DCX repeat can bind to purified tubulin and two intact repeats together are necessary and sufficient for microtubule polymerization and stabilization (Horesh et al., 1999) . Several missense mutations in the DCX repeats lead to impaired polymerization and stabilization of microtubules indicating a physiological role of DCX in microtubule formation (Sapir et al., 2000; Taylor et al., 2000) .
We used the yeast two-hybrid assay to examine the ability of neurabin II (clone 262, Fig. 1A ) to interact with a series of mutant Dcx proteins (Fig. 1D) . Point mutations in the DCX repeat regions did not noticeably affect normal Dcx/neurabin II interaction (data not shown). By contrast, mutations R39X, Q235X and D246X resulted in a complete loss of binding to neurabin II (Fig. 5A, lines d-f ). Dcx R303X , however, that partially lacks the Ser/Pro region, interacted with neurabin II (Fig. 5A, line g ). It had previously been shown that DCX interacts with m1A of the AP-1 adaptor complex through a YLPL tetrapeptide located at amino acids 350-353. Using the yeast two-hybrid assay, three point mutations (Dcx Y350A , Dcx L353A and Dcx Y350A/L353A ) were tested for interaction with neurabin II. All three of these mutant proteins interacted with clone 262 of neurabin II, whereas m1A failed to interact with mutant Dcx (Fig. 5B,  lines g-l) .
Taken together, our studies suggest that the interaction between neurabin II and Dcx primarily involves the coiledcoil region of neurabin II and a region of Dcx extending between amino acids 246 and 303 that encompasses the C-terminal portion of the second doublecortin repeat and the N-terminal portion of the Ser/Pro rich domain (Fig. 1D) . In other words, the interaction between neurabin II and Dcx involves regions of Dcx distinct from those mediating the interactions with either m1A or tubulin.
Discussion
Many proteins required for neuronal migration bind to the cytoskeleton (reviewed in Gleeson and Walsh, 2000; Feng and Walsh, 2001 ). Examples are DCX, a MAP Gleeson et al., 1999) and Lis1 that stabilizes microtubules (Sapir et al., 1997) . Mutations in DCX and Lis1 in humans cause severe defects in the cytoarchitecture of the cerebral cortex as a result of abnormal neuronal migration during cortical development. Neuronal migration requires both microtubule and actin filament networks, but it is not known how both components interact to produce directed cell motility (Walsh and Goffinet, 2000; Feng and Walsh, 2001 ). The present work shows that a MAP, Dcx, interacts with neurabin II/ spinophilin which itself binds to F-actin through a N-terminal F-actin binding domain . In addition to the yeast two-hybrid assays, GST pull-down assays and immunoprecipitation experiments using transfected COS-7 cells, co-immunoprecipitation experiments from embryonic mouse brain have confirmed in vivo neurabin II-DCX interaction. Hence, the present work suggests that the actin and tubulin cytoskeleton in neuronal cells are linked by a Dcx-neurabin II heterodimer. Apart from the interaction with neurabin II, Dcx protein is capable of additional interactions; its DCX repeats bind to microtubules and a C-terminally located tetrapeptide signal serves as binding site for the adaptor complex (AP-1) subunit m1A (Friocourt et al., 2001) . The microtubule-m1A-DCX interaction raises the possibility that DCX participates in protein sorting or vesicular trafficking (Friocourt et al., 2001) .
Using deletion constructs modeled after naturally occurring DCX mutations, the interaction site of Dcx with neurabin II was mapped to a region extending between the C-terminal portion of the second tubulin-binding motif of DCX and the N-terminal part of its Ser/Pro-rich region. The distinct nature of each interaction site raises the possibility that DCX simultaneously interacts with microtubules, m1A and neurabin II. We showed that Dcx binds to the coiled-coil domain of neurabin II. It is interesting to note that Dcx does not bind to neurabin I whose coiled-coil domain has 60% sequence identity with that of neurabin II .
In addition to Dcx, neurabin II binds to several other proteins. Some of these neurabin II-interacting proteins bind to either the PDZ or the coiled-coil domains (Allen et al., 1997; Ide et al., 1998; Satoh et al., 1998; Stephens and Banting, 1999; Vivo et al., 2001 ). An example of a protein binding to the coiled-coil domain of neurabin II is TGN38, a trans-Golgi network transmembrane protein (Stephens and Banting, 1999) . Moreover, neurabin II binds to the third cytoplasmic loop of D2 dopamine receptor. The receptor binds to a region of neurabin II located between the F-actin binding domain and the PDZ domain (Smith et al., 1999) . A putative DCX/neurabin II/microtubule/F-actin complex may be involved in the transport and localization of this receptor and possibly of other G-protein coupled receptors in neurons.
One argument in favor of a functional interaction between Dcx and neurabin II would be in vivo interaction and coexpression of the two proteins. Our in situ hybridization analysis of embryonic, postnatal and adult brain sections demonstrated the coexpression of Dcx and neurabin II in the developing as well as adult brain. Brain extracts from E17.5 embryos were immunoprecipitated with either antibodies against Dcx or against FLAG epitope (control). A Western blot was probed with an anti-neurabin II antibody and after stripping, the same membrane was reprobed with an anti-Dcx antibody. A Dcx antibody precipitates Dcx and simultaneously pulls down neurabin II. The left lane shows Dcx and neurabin II immunoreactivity in brain extract. Fig. 3 . Expression pattern of neurabin II and Dcx in the developing forebrain. (A) At E14.5, expression is detected in the cortical plate and the hippocampus and at a lower level in the ventricular zone. (B) A comparison with an nearby sagittal section hybridized with a sense riboprobe indicates that the blue-purple signal seen in (A) is real. (C) Expression of neurabin II and Dcx detected in a coronal section of a P7 brain. Note the widespread expression of both genes. Elevated expression is seen in layers 2 and 3 of the cortex, the piriform cortex, the olfactory tubercles and in the case of Dcx, in the rostral migratory stream. (D) Section located caudally to that shown in (C) passes through the hippocampus. Both, neurabin II and Dcx are broadly expressed. Note that Dcx but not neurabin II is expressed throughout the dentate gyrus. Abbreviations: aca-anterior commissure anterior, ca-cornu amonis, cc-corpus callosum, ctx-L2/3-neocortex layers 2 and 3, dg-dentate gyrus, gp-globus pallidus, hip-hippocampus, fmi-forceps minor of corpus callosum, lv-left ventricle, ot-olfactory tubercles, pctx-piriform cortex, RMS-rostral migratory stream, s-septum, str-striatum, th-thalamus, vz-ventricular zone. Scalebar in (C): 1000 mm, all images shown have the same magnification.
Although neurabin II expression was low at E14.5 and E18.5 as judged by Western blotting (Allen et al., 1997) , our in situ hybridization detected expression of this gene in a layer of neurons located at the outer margin of the cortical plate where Dcx is known to be strongly expressed (Gleeson et al., 1999) . Furthermore, our yeast two-hybrid analysis showed that several human DCX mutations, such as Q235X and D246X abolish interaction with neurabin II. In part, the absence of this interaction may contribute to lissencephaly and SCLH seen in patients. It should be emphasized, however, that DCX Q235X and DCX D246X also fail to bind m1A (M. Tsukada and G. Eichele, unpublished data) and hence the lissencephalic phenotype may be a combination of lack of binding of neurabin II and m1A to DCX.
Another important finding of this study was coexpression of Dcx and neurabin II in postnatal and adult brain. There is ample evidence that DCX is expressed at high levels in migrating neurons of the embryonic CNS Gleeson et al., 1999) as well as in the migrating neurons of the rostral migratory stream (Gleeson et al., 1999; Nacher et al., 2001) . Immunohistochemical studies demonstrated that neurabin II is highly expressed in dendritic spines of hippocampal neurons and young mice lacking neurabin II have an increased number of dendritic spines (Allen et al., 1997; Feng et al., 2000) . Moreover, the size of the hippocampus was reduced and mutant mice showed several defects in hippocampal functions including a reduction in long-term depression due to a dysregulation of glutamate receptor currents (Feng et al., 2000) . Our in situ hybridization analysis established partial overlap in expression of neurabin II and Dcx in P7 hippocampus indicating that neurabin II and Dcx could function in a concerted fashion in the hippocampus. Consistent with this was the colocalization of Dcx and neurabin II in the hippocampal neurons. In contrast to the massive heterotopia seen in humans lacking a functional DCX, mice lacking Dcx are normal except for a prominent heterotopia in the CA3 region of the hippocampus (Corbo et al., 2002) . Whether this dysmorphology in Dcx 2/2 mice and the change in dendritic spine morphology seen in neurabin II knock-out mice are related remains to be determined. Nevertheless, it is possible that at least in mice, Dcx is required for dendrite elaboration through its interaction with neurabin II.
The mechanism of action of a Dcx-neurabin II complex requires further studies. Does the Dcx-neurabin II complex function as cytolinker protein connecting actin and microtubule networks, such as microtubule actin cross-linking factor (MACF) of the plakin family (Leung et al., 1999 ; ) recognized by m1A. All mutant Dcx proteins interact with neurabin II but not with m1A. Sun et al., 2000; Leung et al., 2002) ? Future experiments will have to determine the biochemical and cellular purpose of Dcx-neurabin II interactions.
Experimental procedures
DNA constructs
The Dcx coding region was subcloned into pEGFP-C3 and pCMV-Tag 2B. Site directed mutagenesis was performed using either the Stratagene Quickchangee SiteDirected Mutagenesis Kit (Stratagene) or GeneEditore in vitro Site-Directed Mutagenesis System (Promega) according to the manufacturer's instructions. Mouse Dcamkl1 cDNA was reverse transcribed from mouse brain RNA and was cloned into pCRII-TOPO and pAS2-1. PCR was utilized to isolate full-length neurabin II from mouse cDNA and was cloned into pAS2-1 and pCMV-Tag 2A. PCR was utilized to isolate full-length neurabin I from the mouse cDNA and was cloned into pAS2-1.
Yeast two-hybrid library screen
Mouse Dcx was generated by RT-PCR and cloned into the NdeI/XmaI sites of the pAS2-1. This construct, encoding a fusion protein of mouse Dcx and the GAL4 DNA binding domain was used as 'bait' for the library screen. A 17-day mouse embryo library made from Swiss Webster/NIH mice was amplified and screened for mouse Dcx-interacting proteins as prescribed by the manufacturer (Clontech). The yeast strain, PJ69-4A (MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4D gal80D GAL2-ADE2 LYS2 < GAL1-HIS3 met2 < GAL7-lacZ), which contains both His3 and Ade2 nutritional reporters (James et al., 1996) , was used for the library screen. Interaction of Dcx fused to GAL4 DNA-BD and a library protein fused to GAL4 AD leads to the expression of a histidine and an adenine reporter gene under the control of a GAL promoter in PJ69-4A and therefore growth on the medium lacking histidine or adenine.
GST pull-down assay
The Dcx cDNA was cloned into pBluescriptSK þ in the forward direction from the T7 site. The C-terminal partial neurabin II coding sequence (amino acids 619 -817) was cloned into pGEX-5X-1. GST-neurabin II were expressed in E. coli XL1-Blue and purified. The TNT Quick Coupled Transcription/Translation Kit (Promega) was used to express [
35 S]methionine-labelled Dcx and Dcamkl1. TNT reaction had a final volume of 20 ml, contained 400 ng of template, 25 mM KCl and was incubated for 60 min at 30 8C. Radiolabelled Dcx proteins were diluted with 140 ml of dilution buffer (67 mM HEPES pH 7.5, 167 mM KCl, 8.3 mM MgCl 2 , 0.3 mM EDTA, 1.67 mM DTT, 0.83% NP40, 4 mM Pefabloc SC, completee [Roche] at the recommended concentration) and incubated with 5 mg of GST or GST-neurabin II and 30 ml of glutathione sepharose 4B (50% slurry). The proteins and beads were incubated at 4 8C overnight with constant rotation. Following incubation, the mixture was centrifuged and 20 ml of the supernatant was prepared for analysis of protein expression (20 ml þ 5 ml 5 £ SDS sample buffer). The beads were washed 3 £ with wash buffer (50 mM HEPES pH 7.5, 4 mM Pefabloc SC, complete [Roche] ) and resuspended in 20 ml of wash buffer with 5 ml of 5 £ SDS sample buffer. All samples were boiled for 3 min at 95 8C before being loaded on a 12% SDS-gel. The gel was fixed (10% MeOH, 10% CH 3 COOH) for 30 min, incubated for 30 min in Amplify solution (Amersham), dried and exposed to Hyperfilm MP (Amersham).
Cell culture and transfection
COS-7 cells (ECACC, UK) were cultured under standard condition as described by Sweeney et al. (2001) . For transient co-transfection, 1-1.5 £ 10 6 cells were plated in 100 mm dishes and incubated overnight to 50-70% confluency. On the next day, the cells were transfected with Effectene (Qiagen) or Lipofectamine Plus (Life Technologies) according to the manufacturer's instructions and incubated at 37 8C for 24-48 h before immunoprecipitation.
Immunoprecipitation
Immunoprecipitation from COS-7 cells and detection of fusion proteins by Western blotting was done in principle as described by Sweeney et al. (2001) . For immunoprecipitation from brain extracts, E17.5 mouse brains were crushed in liquid nitrogen and homogenized in IP buffer (50 mM TrisCl pH 8.0, 120 mM NaCl, 1 mM EDTA, 0.5% NP-40 containing proteinase inhibitors) supplemented with 20 mg/ml latrunculin B. After a centrifugation at 50,000g for 30 min at 4 8C, cleared supernatants were used for immunoprecipitation. Four micrograms of a goat polyclonal anti-Dcx antibody (Santa Cruz) and a rabbit polyclonal anti-FLAG antibody (Sigma), a negative control, were used for immunoprecipitation. Western blotting was carried out with a goat polyclonal anti-Dcx antibody (1:300 dilution) and monoclonal anti-neurabin II antibody (1:1 dilution).
In situ hybridization
In situ hybridization was performed as described by Reymond et al. (2002) .
Primary culture of mouse hippocampal neurons and immunofluorescence staining
Hippocampi were dissected from mouse E18.5 embryos, dissociated, plated on poly-L-lysine-coated glass coverslips and cultured described Goslin et al., 1998) . Immunofluorescence staining of cells on the coverslips was done with standard methods following fixation for 3 min in 2 20 8C methanol. A guinea pig polyclonal antiDcx antibody (Chemicon International) was used at 1:100 dilution. Neurabin II was detected with a mouse monoclonal anti-neurabin II at 1:1 dilution.
